Combined thrombophilic factors increase the risk of recurrent thrombotic events in Behcet's disease

Clinical Rheumatology

Volumn 29, Issue 12, 2010, Pages 1367-1372

  Yaşar, N Şule ^a   Salgür, Füsun ^a   Cansu, Döndü Ü ^a   Kaşifoǧlu, Timuçin ^a   Korkmaz, Cengiz ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Beh et's disease; Coagulation; Recurrent thrombosis; Thrombophilia; Vasculitis

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEIN C; PROTEIN S;

ADULT; ARTHRITIS; ARTICLE; BEHCET DISEASE; CEREBRAL SINUS THROMBOSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE DURATION; FEMALE; GENE MUTATION; GENITAL ULCER; HUMAN; INTRACARDIAC THROMBOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR;

ADULT; BEHCET SYNDROME; BLOOD COAGULATION FACTOR INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS; YOUNG ADULT;

EID: 78649331682     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1455-x     Document Type: Article

References (20)

1. YJ Lee SW Kang JI Yang, et al. 2002 Coagulation parameters and plasma total homocysteine levels in Behçet's disease Thromb Res 106 19 24 1:CAS:528:DC%2BD38XmtVSltbw%3D 10.1016/S0049-3848(02)00085-3 12165284 (Pubitemid 34879960)
2. N Lenk G Ozet N Alli, et al. 1997 Protein C and protein S activities in Behçet's disease as risk factors of thrombosis Int J Dermatol 37 124 125 10.1046/j.1365-4362.1998.00114.x
3. M Leiba Y Sidi H Gur, et al. 2001 Behçet's disease and thrombophilia Ann Rheum Dis 60 1081 1085 1:CAS:528:DC%2BD38XitFeksw%3D%3D 10.1136/ard.60.12.1081 11709446 (Pubitemid 33099993)
4. S Yurdakul H Yazici 2008 Behçet's syndrome Baillieáre's Best Pract Res Clin Rheumatol 22 793 809 10.1016/j.berh.2008.08.005
5. M Leiba U Seligsohn Y Sidi, et al. 2004 Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease Ann Rheum Dis 63 1445 1449 1:CAS:528:DC%2BD2cXhtVWrsbjO 10.1136/ard.2003.014241 15479893 (Pubitemid 39433949)
6. P Durieux O Bletry G Huchon B Wechsler J Chretien P Godeau 1981 Multiple pulmonary arterial aneurysms in Behcet's disease and Hughes-Stovin syndrome Am J Med 71 736 741 1:STN:280:DyaL38%2FitFajsA%3D%3D 10.1016/0002-9343(81)90245-X 7282759 (Pubitemid 12140443)
7. L Mammo A Al-Dalaan SS Bahabri JN Saour 1997 Association of factors V leiden with Behcet's Disease J Rheumatol 24 2196 2198 1:STN:280: DyaK1c%2FktFOgsw%3D%3D 9375883
8. A Gül U Ozbek C Oztürk, et al. 1996 Coagulation factor V gene mutation increases the risk of venous thrombosis in behçet's disease Br J Rheumatol 35 1178 1180 10.1093/rheumatology/35.11.1178 8948311
9. AF Oner A Gürgey A Gürler L Mesci 1998 Factor V Leiden mutation in patients with Behçet's disease J Rheumatol 25 496 498 1:STN:280:DyaK1c7ns12nuw%3D%3D 9517770
10. M Siliagardi A Ghirarduzzi L Lori, et al. 2001 Factor V leiden and G20210A prothrombin alleles are not associated with thrombosis in Behçet's disease Thromb Haemost 85 suppl 2519
11. B Wechsler F Davatchi M Hamza, et al. 1990 Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's disease Lancet 335 1078 1080
12. KK Hampton MA Chamberlain DK Menon JA Davies 1991 Coagulation and fibrinolytic activity in Behçet's disease Thromb Haemost 66 292 294 1:STN:280:DyaK38%2FotFShtQ%3D%3D 1745999
13. A Koşar IC Haznedaroǧlu Y Büyükaşik, et al. 1998 Activated protein C resistance in Behçet's disease Rheumatol Int 17 249 250 10.1007/s002960050043 9592866
14. PB Toydemir AH Elhan A Tükün, et al. 2000 Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease J Rheumatol 27 2849 2854 1:CAS:528:DC%2BD3cXptVehtb8%3D 11128675
15. A Orem O Deger O Memis, et al. 1995 Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behcet's disease Ann Rheum Dis 54 726 729 1:CAS:528:DyaK2MXoslShsrc%3D 10.1136/ard.54.9.726 7495343
16. C Korkmaz T Kasifoglu M KebapcI 2007 Budd-Chiari syndrome in the course of Behcet's disease: clinical and laboratory analysis of four cases Jt Bone Spine 74 245 248 10.1016/j.jbspin.2006.06.015 (Pubitemid 46720041)
17. D Saadoun B Rvechsler M Resche-Rigon, et al. 2009 Cerebral venous thrombosis in Behcet's disease Arthritis Rheum 61 518 526 1:STN:280: DC%2BD1M3mtFagsg%3D%3D 10.1002/art.24393 19333987
18. V de Stefano I Martinelli PM Mannucci, et al. 1999 The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation N Engl J Med 41 801 806 10.1056/ NEJM199909093411104 (Pubitemid 29420475)
19. P Simioni P Prandoni AWA Lensing, et al. 1997 The risk of recurrent venous thromboembolism in patients with an Arg506Gln mutation in the gene for factor V (Factor V Leiden) N Engl J Med 336 399 403 1:CAS:528:DyaK2sXhsVekt74%3D 10.1056/NEJM199702063360602 9010145 (Pubitemid 27081902)
20. C Korkmaz 2008 Is anticoagulation unnecessary in Behcet's disease with deep venous thrombosis? Clin Rheumatol 27 405 406 10.1007/s10067-007-0805-9 18066612